fused with Krebs-Henseleit solution (KHS) (pH 7 .4, 27°C) saturated with 95% 02/5% C02 at a flow rate of 6.4 ml/min . Tissues were equilibrated for 60 min before contraction with norepinephrine (NE) (10 ttM). To avoid oxidation, ascorbic acid (54 UM) was present in the NE-containing perfusion medium . The absence of endothelium was demonstrated by lack of relaxation in response to 10 PM acetylcholine .
Macrophages (M0) were obtained from C3H/HeJ mice (The Jackson Laboratories, Bar Harbor, ME) after intraperitoneal injection of thioglycollate broth 4 d previously, or were the mouse M0-like tumor cell line RAW 264 (American Type Culture Collection, Bethesda, MD) (15) . Mo beads were prepared by allowing M0 (9 x 10' for C3H/HeJ, 1.9-3.4 x 10' for RAW 264) to adhere in tissue culture flasks to 2.1 ml (packed volume) of Cytodex 3 beads (Pharmacia Fine Chemicals, Piscataway, NJ) for 12-24 h in 35 ml ofMinimum Eagle's Medium, a modification, containing 8% calf serum (Hyclone Systems, Logan, UT) at 37°C in 5% C02 . M0 on beads were activated by exposure to rIFN-y (500 U/ml, murine ; Genentech, Inc., South San Francisco, CA) for 12-16 h followed by addition of bacterial LPS (5 t~g/ml ; Escherichia coli 0111 :114, List Biological, Campbell, CA) 5-10 h prior to the experiment . For measurements of N02 -/N03-synthesis, aliquots of the cells on beads were removed from the stock cultures and their subsequent N02-/N03-synthesis was measured over 6-12 h as described previously (2) . After loading into the columns, the M0-bearing beads were washed with two column volumes of KHS before use. After each experiment, the number of macrophages remaining in the columns was determined by lysing the cells and fixing the nuclei for counting in a hemocytometer as described (16) .
Spectrophotometric Assay for NO. and Nitrogen Dioxide (NO2). Ferredoxin (Fd) from Clostridium pasteurianum was dissolved under N2 in deoxygenated PBS (pH 7 .2) to form an 11.3-AM Fd solution (E390 = 24 mM/cm ; reference 17) . This solution (900 P,1, 10.2 nmol) was transferred anaerobically to an N2-flushed anaerobic cuvette. Authentic NO . (Matheson Gas Products, Inc., Rutherford, NJ) that had passed through 1 M KOH was transferred with a gas-tight syringe in sequential 10-141 amounts to the cuvette . After each addition, the cuvette was mixed by several inversions and the spectrum was recorded from 600 to 350 nm in a spectrophotometer (model 557 ; Hitachi Inc., New York, NY) . Reactions of N02 were carried out as with NO . except N02 was not passed through 1 M KOH . After addition of 70 ILI NO-(2 .87 P,mol) or 30 Al of N02 (3.41 14mol), each solution was aerated, the pH was recorded, and N02 -/ N03-concentrations were measured . The results for NO-were pH = 6.01 t .08, N02 -+ N03 -= 3 .01 f .17 mM (% N02 -= 101 ± 4%) . In contrast to the mild acidification caused by NO., addition of 30 Al N02 reduced the pH to 4.05 f 1.47, sometimes precipitating the Fd. The concentration of N02-+ N03 -after addition of 30 JAI N02 was 3 .29 ± .71 mM (% N02 -= 61 ± 26%). For the reaction of N02 -with Fd (n = 3), a 400-mM stock solution of NaN02 was used and the Fd was dissolved in PBS buffered to pH 5.9 with 20 mM morpholinoethane sulfonate to control for the acidification that occurred in the NO-/Fd reaction .
N02 -and N03 -Assay. N02 -and N03-were measured by an automated colorimetric assay based on the Griess reaction described in detail elsewhere (2) . Briefly, samples were reacted with the Griess reagent (1olo sulfanilamide, 0.1% naphthylethylene diamine dihydrochloride, 2.5% H3PO4) and the N02 -concentration was determined by monitoring at 543 nm. N03 -in the sample was measured after reduction of N03 -to N02_ . Data were expressed either in concentration units or as nmoles produced over the indicated time periods. The percentage of N02 -in the sample relative to the total N02-plus N03 -was also determined.
Other Reagents . N°,O-dimethyl-L-arginine (DMA) was from Chemical Dynamics Corp., South Plainfield, NJ . All other chemicals were from Sigma Chemical Co., St. Louis, MO.
Results
Bioassayfor NO. . The bioassay for Mo-derived NO-was based on that for EDRF (3, 4, 10) . A ring of rabbit thoracic aorta was denuded of endothelial cells and superfused with the admixture of two streams of KHS, one containing 10 14M NE and the other exiting one oftwo columns : an empty control column, or an experimental column containing Cytodex beads to which C3H/Hej mouse peritoneal M0 or RAW 264 mouse M0-like tumor cells had adhered. The M0 were activated for N02-/N03 -production, either by prior exposure to rIFN-y and LPS (8) , or to a lesser degree, by exposure to the Cytodex beads themselves . The M0 perfusate elicited a relaxation of the precontracted arterial ring in six of six experiments. Addition of 0.5 MM L-arginine to the solution perfusing the M0 column augmented the vasorelaxation . The degree of augmentation by L-arginine was inversely proportional to the extent of relaxation induced by the M0 perfusate without addition of L-arginine (Fig. 1) .
Ferrous hemeproteins react with NO . with high affinity (18) , and block vasorelaxation mediated by NO . (19) . Similarly, perfusion of the M0 column with ferrous myoglobin (either reduced by ascorbate [ The inhibition specifically required hemeprotein, because ascorbate alone did not reverse the M0-induced relaxation (not shown) . Inhibition of vasorelaxation by myoglobin/ascorbate was not due to toxicity to the M0, because removal of myoglobin/ascorbate from the perfusion buffer led to immediate restoration of M0-mediated relaxation in all cases. L-arginine and myoglobin/ascorbate did not act directly on the arterial ring, because L-arginine and myoglobin/ascorbate caused neither contraction nor relaxation when perfused through an empty column directly onto the ring (Fig . 1 B) .
The vasorelaxing factor released from the M0 was short lived. As shown in Fig. 1 , A and B, collected column effluent had no vasorelaxing effect when it was passed over the aortic ring a second time. Indomethacin had no effect on M0-mediated vasorelaxation ( Fig . 1 C) , militating against a role for cyclooxygenase metabolites (10) . However, vasorelaxation was reversed 50% upon addition of 10',M methylene blue ( Fig . 1 B) , an inhibitor of guanylate cyclase in vascular smooth muscle (19) , suggesting that the M0-derived vasorelaxant, like NO ., acts through activation of this enzyme (4, 13) .
N°-methylated arginine analogs serve as competitive inhibitors of synthesis of N02_/NO3_ in M0 (6, 20) and NO . in endothelial cells (21, 22) . Perfusion of 0.13 mM N°N~-dimethyl-L-arginine (DMA) through the RAW 264 M0 column completely blocked production of the relaxing factor ( Fig . 1 D) . Addition of 2.5 mM L-arginine to the perfusion medium containing DMA reversed the inhibition and potentiated the production of the M0-derived relaxing factor. Similar results were seen with C3H/He M0 using the related inhibitor N~-monomethylarginine (not shown) . This indicated that generation of the relaxing factor was closely associated with M0 metabolism of L-arginine to N02-/N03 -. However, authentic NaN02 relaxed arterial rings only at concentrations above 50,uM; 50% relaxation required 2.5 mM N02-(n = 3, not shown) . Although the M0 used in these experiments were actively synthesizing N02-(see Fig. 1, legend) , the N02-concentration in the effluent of M0 columns that relaxed the aortic ring was only 1.8 /AM (n = 3, Fig. 1  C) . Thus, N02-itself was not responsible for the vasorelaxation .
In sum, production of the M0-derived vasorelaxant was augmented by L-arginine and inhibited by arginine analogs methylated on a guanido nitrogen . N02-was not the active principle. The vasorelaxant was scavenged by ferrous myoglobin. It was highly labile in an aerated aqueous solution at pH 7.4 . Its actions were blocked by methylene blue but not indomethacin . These are hallmarks of NO . (3, 4, 7, 19, 21) . Spectrophotometric Assay for N0. and N02. Next, we wished to find a molecule that would react with Mo-derived NO. under aerobic tissue culture conditions and thus serve as an independent assay of NO-production . The cultures had to be aerobic to permit Mo generation of nitrogen oxides. Trapping NO. was necessary, because in aerated solutions, NO . reacts rapidly with 02 to form nitrogen dioxide (N02), which in turn reacts with water to yield NO2-and N03-. Thus, if NO. is produced by M0, it will not accumulate .
Mass spectroscopy has been used to measure NO-in endothelial cell perfusates after their collection into a solution of refluxing potassium iodide/acetic acid (7). However, this method does not discriminate between NO. released by endothelial Spectroscopic assay of reaction of clostridial ferredoxin (Fd) with three oxides of nitrogen . (Mainfigure) Fd was dissolved under N2 in deoxygenated PBS (pH 7 .2) to form an 11 .3-/4M Fd solution, of which 900,u1 (10 .2 nmol) was transferred anaerobically to an N2-flushed anaerobic cuvette. Authentic NO . that had passed through 1 M KOH was transferred with a gas-tight syringe in sequential 10 Wl amounts to the cuvette. After each addition, the cuvette was mixed by several inversions and the spectrum recorded from 600 to 350 nm. (O), N02 (A), or NO2-(p) . Reactions of NO-(n = 4) and N02 (n = 3) gas were carried out as above; reaction of N02-with Fd (n = 3) was done in PBS buffered to pH 5.9 as described in Materials and Methods. cells and NO-arising in the collection vessel via reduction of N02-. Hemeproteins have been used to trap NO- (4, 23) . Preliminary experiments revealed that although nitrosyl-heme complexes were stable in an anaerobic atmosphere, they decomposed rapidly in aerated culture medium (not shown) . In view of these drawbacks, we turned to Fe-S proteins . NO , reacts irreversibly with some Fe-S proteins (24) , decreasing their absorbance in the visible spectrum . Thus, bleaching of Fe-S chromophores could serve as a cumulative measure of NO-release. Indeed, authentic NO-caused concentration-dependent bleaching of the visible spectrum of clostridial ferredoxin (Fd), an 8-iron, 8-sulphur Fe-S protein (Fig . 2) . The absorbance of Fd at 410 decreased in a linear fashion with increasing amounts of NO-up to 2 /Amol (Fig . 2, lower inset) . The absorbance of Fd in the ultraviolet was unchanged under the same conditions (upper inset), demonstrating that the decrease in absorbance in the visible region was not due to dilution of the chromophore, and suggesting that the reaction of NO . with Fd was relatively specific for the Fe-S clusters . Authentic N02 also bleached Fd (lower inset) . In this case, acidification caused by hydration of N02 complicated interpretation of the dose curve above 2 p.mol N02 . In contrast, N02-did not bleach Fd, even at pH 5 .9 (lower inset) . Finally, the spectrum of Fd was stable over at least 19 h in tissue culture medium at 37°C .
Thus, we used bleaching of Fd to test for NO ./NO2 production by activated M0
in culture (Fig . 3) . Mo bleached Fd ; the magnitude of bleaching was proportional to time, cell number, and the concomitant production of N02_ -Only a minor amount of Fd bleaching occurred in M0 cultures in which synthesis of nitrogen oxides was blocked by omitting L-arginine, even when exogenous NaN02 was added at the start of the coincubation with Fd . Thus, the only Mo product(s) required for substantial bleaching appeared to be those distal to L-arginine and proximal to N02 -in the biosynthetic pathway of nitrogen oxides . Hypohalous acids can also bleach Fd (25), but were not involved in this case, because production of H202, the precursor of hypohalous acids, is not dependent on L-arginine (26) , and in any event the addition of catalase to break down H202 had no effect on Mo bleaching of Fd . Unfortunately, control Mo (those not producing N02 _ /NO3 _ ) could not be tested in this system, because Fd itself partially activated the cells for N02_/NO3_ synthesis (not shown) .
Discussion The combined evidence from the biological and biochemical assays described above strongly suggests that activated Mo release an L-arginine-derived compound that is either NO . or a closely related substance with similar reactivity, such as N02. Compared with agonist-triggered endothelial cells (3, 4, 10) , activated Mo secrete the NO--like compound over much longer periods, and the total amount produced per cell may be far greater. The factors inducing NO . release require more study, but are probably similar to those inducing secretion of N02-/NO3 -. Inducers of N02_/NO3_ include LPS and IFN-y, or synergistic combinations of IFN-'Y with TNF, or LPS with IFN-a or IFN-a (8, 9) .
Although Mo release of the NO--like compound was augmented by exogenous L-arginine and completely blocked by DMA, variable amounts were still released by Mo in the absence of exogenous L-arginine (Fig . 1) . This suggests existence of sources of L-arginine within the Mo. Such sources are probably short lived, since this metabolic pathway exhibits a strict requirement for exogenous L-arginine when measured over longer time periods (5) .
These findings prompt a number of speculations about the role of NO . secretion in the physiology of Mo. First, NO . may be a specific mediator of arginine-dependent antitumor and antimicrobial effects of Mo, including inactivation of the target cell Fe-S enzymes cis-aconitase (27) , succinate:ubiquinone oxidoreductase, and NADH :ubiquinone oxidoreductase (28) . Second, Mo may play a previously unsuspected part in regulating smooth muscle tone during inflammatory or immune responses. Interest in this hypothesis is heightened by the abundance of Mob in the renaljuxtaglomerular apparatus and interstitium (29) , gastrointestinal mucosa (30), bronchial epithelium (31), pulmonary vasculature, interstitium, and alveoli (31) , and sinusoids of liver, spleen, and marrow, as well as in wounds, granulomas, and atheromas. For example, the mononuclear phagocytes associated with blood vessels may affect systemic blood pressure during sepsis, or regional blood flow in inflammation and wound healing. Third, secretion of NO . by vessel-associated M0 or monocytes could influence not only smooth muscle cells and platelets but also endothelial cells. Fourth, in lymphocytes, activation of guanylate cyclase or inactivation of certain Fe-S enzymes by NO . might contribute to Mo-mediated stimulation or suppression of immune responses. Summary L-arginine-dependent synthesis of nitrite (N02-) and nitrate (N03-) by macrophages correlates with and is required for their execution of nonspecific cytotoxicity toward some tumor cells and microbes. However, the bioactive L-arginine metabolites responsible for cytotoxicity are unknown . Mammalian endothelial cells have recently been shown to release nitric oxide (NO .); we therefore determined if this reactive metabolite was synthesized by activated murine macrophages. Macrophagederived NO. was detected by two independent methods : a bioassay for NO .-mediated relaxation ofpreconstricted rings of rabbit aorta; and a spectroscopic measurement of the reaction of NO . with clostridial ferredoxin, an Fe-S protein . After activation with IFN-'Y and LPS, macrophages continuously secreted a substance that relaxed rabbit aortic rings denuded ofendothelium. Production of the vasorelaxant was enhanced by 0 .5 MM L-arginine and inhibited reversibly by 0-methylated L-arginine analogs that block macrophage N02_/NO3_ synthesis . The vasorelaxant was scavenged by ferrous myoglobin, was labile, and was neither N02 -nor a cyclooxygenase metabolite. Activated M0 also secreted a substance that bleached Fd, a reaction carried out by NO . and N02, but not N02". Macrophage bleaching of Fd correlated directly with time, cell number, and concomitant N02 -/N03-production, required L-arginine, and was independent of reactive oxygen intermediates . Thus, activated murine M0 release NO . and/or a closely related, highly reactive nitrogen oxide such as N02, during their conversion of L-arginine to N02 -/NO3". NO . and N02 may mediate L-arginine-dependent pathologic effects of M0, as well as physiologic effects not previously considered for this widely distributed cell type.
